Jim Simons
TRIB

Jim Simons’s Trinity Biotech TRIB Stock Holding History

Jim Simons’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.63K Sell
592
-83
-12% -$1.83K ﹤0.01% 3198
2025
Q4 		$16K Sell
675
-5,037
-88% -$149K ﹤0.01% 3159
2025
Q3 		$178K Buy
5,712
+3,813
+201% +$120K ﹤0.01% 3151
2025
Q2 		$37K Sell
1,899
-657
-26% -$13.2K ﹤0.01% 3425
2025
Q1 		$43.7K Sell
2,556
-3,746
-59% -$88.7K ﹤0.01% 3301
2024
Q4 		$166K Sell
6,302
-2,036
-24% -$81.7K ﹤0.01% 3210
2024
Q3 		$275K Sell
8,338
-510
-6% -$34.5K ﹤0.01% 3009
2024
Q2 		$565K Sell
8,848
-64
-0.7% -$3.73K ﹤0.01% 2637
2024
Q1 		$545K Sell
8,912
-114
-1% -$8.01K ﹤0.01% 2825
2023
Q4 		$581K Sell
9,026
-62
-0.7% -$4.44K ﹤0.01% 2722
2023
Q3 		$1M Sell
9,088
-64
-0.7% -$7.87K ﹤0.01% 2292
2023
Q2 		$1.31M Sell
9,152
-27
-0.3% -$3.92K ﹤0.01% 2294
2023
Q1 		$1.29M Sell
9,179
-111
-1% -$17.2K ﹤0.01% 2299
2022
Q4 		$1.38M Sell
9,290
-298
-3% -$54.2K ﹤0.01% 2327
2022
Q3 		$1.54M Sell
9,588
-434
-4% -$83.9K ﹤0.01% 2213
2022
Q2 		$1.84M Buy
10,022
+232
+2% +$42.5K ﹤0.01% 2246
2022
Q1 		$1.56M Sell
9,790
-667
-6% -$115K ﹤0.01% 2420
2021
Q4 		$2.24M Sell
10,457
-1,189
-10% -$337K ﹤0.01% 2053
2021
Q3 		$3.77M Sell
11,646
-688
-6% -$242K ﹤0.01% 1634
2021
Q2 		$5.44M Buy
12,334
+34
+0.3% +$17K 0.01% 1585
2021
Q1 		$6.94M Sell
12,300
-412
-3% -$297K 0.01% 1449
2020
Q4 		$7.26M Buy
12,712
+1,537
+14% +$763K 0.01% 1365
2020
Q3 		$3.39M Buy
11,175
+654
+6% +$227K ﹤0.01% 1804
2020
Q2 		$3.44M Buy
10,521
+4,693
+81% +$1.07M ﹤0.01% 1856
2020
Q1 		$962K Buy
5,828
+1,247
+27% +$196K ﹤0.01% 2444
2019
Q4 		$710K Buy
4,581
+45
+1% +$6.42K ﹤0.01% 2771
2019
Q3 		$823K Sell
4,536
-34
-0.7% -$8.86K ﹤0.01% 2670
2019
Q2 		$1.13M Buy
4,570
+478
+12% +$171K ﹤0.01% 2626
2019
Q1 		$1.75M Buy
4,092
+121
+3% +$49.9K ﹤0.01% 2378
2018
Q4 		$1.36M Buy
3,971
+43
+1% +$19.9K ﹤0.01% 2431
2018
Q3 		$2.36M Buy
3,928
+276
+8% +$180K ﹤0.01% 2196
2018
Q2 		$2.74M Buy
3,652
+578
+19% +$417K ﹤0.01% 2113
2018
Q1 		$2.37M Buy
3,074
+415
+16% +$340K ﹤0.01% 2238
2017
Q4 		$2.03M Buy
2,659
+803
+43% +$621K ﹤0.01% 2337
2017
Q3 		$1.56M Buy
1,856
+316
+21% +$264K ﹤0.01% 2400
2017
Q2 		$1.39M Buy
1,540
+442
+40% +$376K ﹤0.01% 2443
2017
Q1 		$981K Buy
1,098
+192
+21% +$180K ﹤0.01% 2548
2016
Q4 		$941K Sell
906
-677
-43% -$699K ﹤0.01% 2562
2016
Q3 		$3.14M Buy
1,583
+499
+46% +$932K 0.01% 1920
2016
Q2 		$1.84M Sell
1,084
-210
-16% -$355K ﹤0.01% 2240
2016
Q1 		$2.26M Sell
1,294
-53
-4% -$84.4K ﹤0.01% 2143
2015
Q4 		$2.38M Sell
1,347
-114
-8% -$202K 0.01% 2001
2015
Q3 		$2.51M Sell
1,461
-328
-18% -$792K 0.01% 1863
2015
Q2 		$4.85M Buy
1,789
+143
+9% +$371K 0.01% 1456
2015
Q1 		$4.75M Sell
1,646
-520
-24% -$1.44M 0.01% 1399
2014
Q4 		$5.69M Sell
2,166
-702
-24% -$1.81M 0.01% 1196
2014
Q3 		$7.86M Sell
2,868
-139
-5% -$452K 0.02% 915
2014
Q2 		$10.4M Buy
3,007
+5
+0.2% +$17.8K 0.02% 816
2014
Q1 		$10.9M Sell
3,002
-233
-7% -$916K 0.03% 816
2013
Q4 		$12.2M Sell
3,235
-153
-5% -$551K 0.03% 694
2013
Q3 		$11.1M Buy
3,388
+688
+25% +$2.01M 0.03% 747
2013
Q2 		$6.83M Buy
+2,700
New +$6.72M 0.02% 928

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
WN
Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jim Simons's TRIB Position: Q1 2026 in Review

Jim Simons reduced its Trinity Biotech (TRIB) stake by 12% in Q1 2026, selling an estimated $1.83K and leaving 592 shares worth $9.63K. The position accounts for ﹤0.01% of the portfolio, ranked #3198.

Jim Simons first reported a position in TRIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.2M in Q4 2013. 21 funds tracked by Wall St. Rank hold TRIB as of Q1 2026.

  • Jim Simons held 592 shares of Trinity Biotech worth $9.63K as of Q1 2026.
  • Jim Simons sold 83 Trinity Biotech shares in Q1 2026, an estimated $1.83K.
  • Trinity Biotech made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #3198 holding.
  • Jim Simons first reported a position in Trinity Biotech in Q2 2013 and has held it in 52 quarters since.
  • Jim Simons's Trinity Biotech position peaked at $12.2M in Q4 2013.
  • 21 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.